Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
21.7M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
8.78M
-
Shares change
-
+169K
-
Total reported value, excl. options
-
$120M
-
Value change
-
+$1.31M
-
Number of buys
-
24
-
Number of sells
-
-25
-
Price
-
$13.60
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q3 2021
58 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q3 2021.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.78M shares
of 21.7M outstanding shares and own 40.5% of the company stock.
Largest 10 shareholders include COWEN AND COMPANY, LLC (1.38M shares), WASATCH ADVISORS INC (1.1M shares), RTW INVESTMENTS, LP (821K shares), BlackRock Inc. (584K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (513K shares), VANGUARD GROUP INC (510K shares), MORGAN STANLEY (499K shares), PLATINUM INVESTMENT MANAGEMENT LTD (400K shares), Stonepine Capital Management, LLC (391K shares), and Samjo Capital LLC (295K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.